Opus Genetics (IRD) Stock: Buy, Sell, or Hold?
$3.98
-0.08 (-1.97%)
âŧ
5d:
-4.78%
30d:
-1.73%
90d:
+9.04%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
39/100
Position
FAIR
30-Day Fair Range
$3.69 â $4.38
Position: FAIR
Forward P/E & Valuation
-5.3x
Next 12M consensus est.
Wall Street Target
$13.94
+250.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.61 / $4.52
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IRD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IRD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IRD is currently trading at $3.98, which is considered fair relative to its 30-day fair value range of $3.69 to $4.38.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $3.61, while resistance sits at $4.52.
Market Sentiment: IRD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.94 (+250.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $3.61, while resistance sits at $4.52.
Market Sentiment: IRD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.94 (+250.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.69 -
$4.38
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$3.69 -
$4.38
Current vs Trading Range
FAIR
Support Level
$3.61
Resistance Level
$4.52
Current Trend
Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 250.3% below Wall St target ($13.94)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.33
Wall Street Target
$13.94
(+250.3%)
Revenue Growth (YoY)
-63.1%
Share IRD Analysis
Share this live IRD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IRD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Wedbush and Chardan Capital raised their price targets for $IRD to $13 and $16, respectively.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:28 PM ET
Data refreshes hourly during market hours. Next update: 6:28 PM
Data refreshes hourly during market hours. Next update: 6:28 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 52 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 43 HOLD |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IRD Research Pages